Scarica l'app Stockscreener
0.3465
2.55%
0.0086
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GBIO Giù?
Forum
Previsione
Precedente Chiudi:
$0.3379
Aprire:
$0.3357
Volume 24 ore:
672.91K
Relative Volume:
1.35
Capitalizzazione di mercato:
$28.50M
Reddito:
-
Utile/perdita netta:
$-126.61M
Rapporto P/E:
-0.1768
EPS:
-1.96
Flusso di cassa netto:
$-60.14M
1 W Prestazione:
-2.42%
1M Prestazione:
-13.11%
6M Prestazione:
-69.87%
1 anno Prestazione:
-85.80%
Intervallo 1D:
$0.3302
$0.3574
Intervallo di 1 settimana:
$0.3004
$0.37
Portata 52W:
$0.3004
$3.65
Generation Bio Co Stock (GBIO) Company Profile
Nome
Generation Bio Co
Settore
Industria
Telefono
857-529-5908
Indirizzo
301 BINNEY STREET, CAMBRIDGE
Confronta GBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
0.3567 | 28.50M | 0 | -126.61M | -60.14M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-10-19 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-12-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-02-24 | Iniziato | William Blair | Outperform |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-07-07 | Iniziato | Cowen | Outperform |
| 2020-07-07 | Iniziato | JP Morgan | Overweight |
| 2020-07-07 | Iniziato | Jefferies | Buy |
| 2020-07-07 | Iniziato | Wedbush | Outperform |
Mostra tutto
Generation Bio Co Borsa (GBIO) Ultime notizie
Post Bio announced on the 17th that it held a kick-off event for the open innovation project and sig.. - 매일경제
64x Bio Launches AAV Apex Suite to Power the Next Generation of Gene Therapy Manufacturing - Business Wire
Millennium Management LLC Makes New $97,000 Investment in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Two Sigma Investments LP Sells 29,496 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Squarepoint Ops LLC Takes Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
What Did We Note About Insider Trading At Generation Bio Co (NASDAQ: GBIO)? - Stocksregister
Generation Bio Elects Directors and Approves Key Proposals - TipRanks
Deutsche Bank AG Buys 160,822 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference | GBIO Stock News - GuruFocus
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times
Generation Bio Reveals Latest T Cell Therapy Progress: CEO Set for Major Jefferies Healthcare Conference Spotlight - Stock Titan
Generation Bio’s SWOT analysis: t-cell targeting tech reshapes stock outlook By Investing.com - Investing.com South Africa
D. E. Shaw & Co. Inc. Has $366,000 Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio’s SWOT analysis: t-cell targeting tech reshapes stock outlook - Investing.com Nigeria
Pharma giant Eli Lilly eyes Houston for $5.9B biomanufacturing plant that could bring over 2,000 jobs - Houston Chronicle
Dimensional Fund Advisors LP Has $420,000 Stock Holdings in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Wedbush Issues Negative Forecast for Generation Bio Earnings - Defense World
Needham & Company LLC Reaffirms “Buy” Rating for Generation Bio (NASDAQ:GBIO) - Defense World
Generation Bio Co (GBIO)’s Market Momentum: Closing Strong at 0.48, Down -6.25 - DWinneX
Generation Bio Co. Reports Reduced Losses and Increased Revenue - TipRanks
Where Generation Bio Stands With Analysts - Benzinga
Needham Reiterates Buy Rating for Generation Bio (GBIO) | GBIO Stock News - GuruFocus
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results - The Manila Times
Generation Bio earnings beat by $0.08, revenue topped estimates - Investing.com
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Metric Deep Dive: Understanding Generation Bio Co (GBIO) Through its Ratios - DWinneX
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Stately Bio Raises $12M Seed to Develop Next Generation Regenerative Medicines with ML-Powered Cellular Imaging Platform - WebWire
Renaissance Technologies LLC Has $1.02 Million Stock Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Revolutionary Green Innovation: Braskem's Bio-Based Polyethylene Transforms Nonwovens Industry - Stock Titan
Generation Bio Co [GBIO] stock for 120,759 USD was acquired by Quinn Anthony G. - knoxdaily.com
GBIO’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
Generation Bio Co (GBIO) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com
Generation Bio Insiders Recover Some Losses, Which Stand At US$115k - simplywall.st
Generation Bio Co (NASDAQ: GBIO) Stock Is A Good Option To Consider - Stocksregister
Next-Generation Biomanufacturing Market Current Scenario with Future Trends Analysis to 2031 - openPR.com
Needham & Company LLC Reaffirms Buy Rating for Generation Bio (NASDAQ:GBIO) - Defense World
GBIO stock plunges to 52-week low of $0.34 amid market challenges - Investing.com Australia
GBIO stock plunges to 52-week low of $0.34 amid market challenges By Investing.com - Investing.com South Africa
LG Innotek, KAIST collaborate for next gen technology - 매일경제
Baker Hughes Co [BKR] Shares Rise 0.27 % on Wednesday - knoxdaily.com
Generation Bio stock hits 52-week low at $0.4 amid steep decline - Investing.com Australia
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference - The Manila Times
Generation Bio Co Azioni (GBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Generation Bio Co Azioni (GBIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Quinn Anthony G. | Director |
Jan 13 '25 |
Buy |
0.97 |
85,000 |
82,450 |
299,286 |
| Howze Yalonda | CHIEF LEGAL OFFICER |
Oct 15 '24 |
Option Exercise |
2.42 |
3,347 |
8,100 |
15,169 |
0.34%
7.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):